E. Schvoerer

H. Melliez, J. Murray, F. Goehringer, 2019, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

NS3 Protease Polymorphism and Natural Resistance to Protease Inhibitors in French Patients Infected with HCV Genotypes 1–5

J. Izopet, P. Colson, P. Trimoulet, 2011, Antiviral therapy.

Multiorgan and Vascular Tropism of SARS-CoV-2

L. Martrille, C. Hartard, I. Koscinski, 2022, Viruses.

Fatal Cowpox Virus Infection in Human Fetus, France, 2017

C. Peyrefitte, O. Ferraris, S. Hénard, 2021, Emerging infectious diseases.

A hospital outbreak of gastroenteritis possibly related to the contamination of tap water by a small round structured virus.

H. Fleury, V. Dubois, A. Rogues, 1999, The Journal of hospital infection.

Co-detection of SARS-CoV-2 and other respiratory pathogens: Lessons from the field to face the second wave

L. Andréoletti, C. Hartard, C. Alauzet, 2020, Journal of Clinical Virology.

Atypical symptoms in patients with herpesvirus DNA detected by PCR in cerebrospinal fluid.

F. Stoll-Keller, J. Gut, E. Schvoerer, 2006, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Lack of effect of tumor necrosis factor-alpha -308 G/A polymorphism on severity of liver fibrosis in Tunisian hepatitis C virus (HCV)-infected patients.

L. Chouchane, H. Triki, H. Triki, 2010, Gastroenterologie clinique et biologique.

Lamivudine therapy of chronic hepatitis B in three groups of patients: non transplanted patients, liver recipients, and kidney recipients.

V. de Lédinghen, P. Couzigou, H. Fleury, 2002, Gastroenterologie clinique et biologique.

Early assessment of diffusion and possible expansion of SARS-CoV-2 Lineage 20I/501Y.V1 (B.1.1.7, variant of concern 202012/01) in France, January to March 2021

C. Charpentier, S. Cauchemez, J. Pawlotsky, 2021, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

SARS-CoV-2 Variability in Patients and Wastewaters—Potential Immuno-Modulation during the Shift from Delta to Omicron

I. Bertrand, C. Gantzer, C. Hartard, 2022, Biomedicines.

Hepatitis B virus mutations potentially conferring adefovir/tenofovir resistance in treatment-naive patients.

T. Baumert, S. Fafi-Kremer, F. Stoll-Keller, 2009, World journal of gastroenterology.

Influence of the HCV subtype on the virological response to pegylated interferon and ribavirin therapy

J. Izopet, D. Roulot, P. Colson, 2009, Journal of medical virology.

Different precore/core mutations of hepatitis B interact with, limit, or favor liver fibrosis severity

S. Bertrais, S. Castelain, B. Roquebert, 2016, Journal of gastroenterology and hepatology.

Impact of protease inhibitors on intrahepatic hepatitis C virus viral load.

D. Neau, J. Ragnaud, M. Dupon, 2001, AIDS.

Real-life rilpivirine resistance and potential emergence of an E138A-positive HIV strain in north-eastern France.

N. Agrinier, C. Rabaud, S. Hénard, 2014, The Journal of antimicrobial chemotherapy.

Seroprevalence of SARS-CoV-2, Symptom Profiles and Sero-Neutralization in a Suburban Area, France

P. Vallois, K. Legrand, N. Jay, 2021, Viruses.

Seroprevalence of SARS-CoV-2, symptom profiles and seroneutralization during the first COVID-19 wave in a suburban area, France

P. Vallois, K. Legrand, Francis Guillemin, 2021, medRxiv.

Transmission of hepatitis E virus by water: An issue still pending in industrialized countries.

S. Berger, I. Bertrand, C. Gantzer, 2019, Water research.

Characterization of hepatitis B virus surface antigen variability and impact on HBs antigen clearance under nucleos(t)ide analogue therapy

C. Combet, F. Zoulim, A. M. Ismail, 2016, Journal of viral hepatitis.

Hepatitis B exacerbation with a precore mutant virus following withdrawal of lamivudine in a human immunodeficiency virus-infected patient.

D. Neau, J. Ragnaud, H. Fleury, 2000, The Journal of infection.

CD4 T lymphocyte proliferative responses to hepatitis C virus (HCV) antigens in patients coinfected with HCV and human immunodeficiency virus who responded to anti-HCV treatment.

M. Houghton, D. Neau, J. Ragnaud, 2002, The Journal of infectious diseases.

Impact of deletions and mutations in Hepatitis B virus envelope proteins on serological profile and clinical evolution.

F. Zoulim, C. Rabaud, F. Goehringer, 2017, Virus research.

Evaluation of three commercially available hepatitis C virus antibody detection assays under the conditions of a clinical virology laboratory.

M. Ullmann, F. Stoll-Keller, N. Meyer, 2005, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

The variability of hepatitis B envelope is associated with HBs antigen persistence in either chronic or acute HBV genotype A infection.

F. Zoulim, S. Berger, J. Bronowicki, 2017, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Emerging hepatitis E virus compared with hepatitis A virus: A new sanitary challenge

C. Gantzer, C. Hartard, J. Bronowicki, 2019, Reviews in medical virology.

Full‐length genome sequencing of RNA viruses—How the approach can enlighten us on hepatitis C and hepatitis E viruses

S. Berger, C. Hartard, J. Bronowicki, 2020, Reviews in medical virology.

Loss of hepatitis B surface antigen in a real‐life clinical cohort of patients with chronic hepatitis B virus infection

T. Baumert, F. Habersetzer, N. Meyer, 2015, Liver international : official journal of the International Association for the Study of the Liver.

Frequent compartmentalization of hepatitis C virus with leukocyte-related amino acids in the setting of liver transplantation.

T. Baumert, S. Fafi-Kremer, C. Royer, 2008, The Journal of infectious diseases.

Multicenter Quality Control of Hepatitis C Virus Protease Inhibitor Resistance Genotyping

C. Charpentier, J. Pawlotsky, J. Izopet, 2013, Journal of Clinical Microbiology.

Naturally Occurring Resistance-Associated Variants of Hepatitis C Virus Protease Inhibitors in Poor Responders to Pegylated Interferon-Ribavirin

J. Pawlotsky, H. Fleury, G. Duverlie, 2015, Journal of Clinical Microbiology.

Clinical impact of hepatitis B and C virus envelope glycoproteins.

J. Murray, E. Schvoerer, H. Jeulin, 2013, World journal of gastroenterology.

Intrahepatic HCV RNA loads in 37 HIV‐HCV co‐infected patients with controlled HIV infection

D. Neau, J. Ragnaud, M. Dupon, 2002, Journal of medical virology.

Persistent Multiple Pulmonary Nodules in a Nonimmunocompromised Woman after Varicella-Related Myelitis Treated with Acyclovir

H. Jouin, B. Gasser, F. Stoll-Keller, 2003, Journal of Clinical Microbiology.

Surveillance of HIV-1 primary infections in France from 2014 to 2016: toward stable resistance, but higher diversity, clustering and virulence?

V. Calvez, C. Charpentier, C. Delaugerre, 2019, The Journal of antimicrobial chemotherapy.

Evolutionary history of hepatitis C virus genotype 5a in France, a multicenter ANRS study.

M. Van Ranst, J. Izopet, D. Roulot, 2011, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

Primary hepatitis C virus infection in an intravenous drug user: kinetics of virological markers.

M. Ullmann, F. Stoll-Keller, J. Gut, 2006, Gastroenterologie clinique et biologique.

Conservation of hepatitis C virus nonstructural protein 3 amino acid sequence in viral isolates during liver transplantation

J. Pinho, T. Baumert, D. Silvestre, 2009, Journal of viral hepatitis.

NS5AISDR‐V3 region genetic variability of Tunisian HCV‐1b strains: Correlation with the response to the combined interferon/Ribavirin therapy

L. Chouchane, H. Triki, H. Triki, 2009, Journal of medical virology.

Sequence analysis of env C2/V3, gag p17/p24, and pol protease regions of 25 HIV type 1 isolates from Ho Chi Minh City, Vietnam.

H. Fleury, F. Barré-Sinoussi, P. Roques, 2001, AIDS research and human retroviruses.

Production of interleukin‐18 and interleukin‐12 in patients suffering from chronic hepatitis C virus infection before antiviral therapy

M. Navas, F. Stoll-Keller, F. Habersetzer, 2003, Journal of medical virology.

Long-term ACE Inhibitor/ARB Use Is Associated With Severe Renal Dysfunction and Acute Kidney Injury in Patients With Severe COVID-19: Results From a Referral Center Cohort in the Northeast of France

J. Olivier, A. Kimmoun, L. Frimat, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Coronavirus disease 2019: acute Fanconi syndrome precedes acute kidney injury

L. Frimat, A. Oussalah, F. Namour, 2020, Clinical kidney journal.

SARS-CoV-2 seroprevalence in healthcare workers and risk factors

L. Peyrin-Biroulet, N. Agrinier, C. Rabaud, 2022, Infection, Disease & Health.

First cases of Omicron in France are exhibiting mild symptoms, November 2021–January 2022

V. Calvez, Y. Yazdanpanah, J. Pawlotsky, 2022, Infectious diseases now.

Seroprevalence and SARS-CoV-2 invasion in general populations: A scoping review over the first year of the pandemic

K. Legrand, A. Gégout-Petit, E. Schvoerer, 2023, PloS one.

Scavenger receptor class B type I is a key host factor for hepatitis C virus infection required for an entry step closely linked to CD81

Ralf Bartenschlager, François-Loïc Cosset, Catherine Schuster, 2007, Hepatology.

Early decrease in circulating dendritic cells number after liver transplantation could favor hepatitis C virus recurrence

D. Jaeck, C. Royer, N. Brignon, 2006, Journal of medical virology.

Anti-SARS-CoV-2 Vaccines and Monoclonal Antibodies Facing Viral Variants

C. Hartard, E. Schvoerer, Ahlam Chaqroun, 2021, Viruses.

Emerging resistance mutations in PI-naive patients failing an atazanavir-based regimen (ANRS multicentre observational study)

V. Calvez, C. Charpentier, C. Delaugerre, 2018, The Journal of antimicrobial chemotherapy.

Impact of Human Immunodeficiency Virus Type 1 Minority Variants on the Virus Response to a Rilpivirine-Based First-line Regimen

V. Calvez, C. Charpentier, F. Brun-Vézinet, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Association of interleukin‐18 polymorphisms and plasma level with the outcome of chronic HCV infection

L. Chouchane, H. Triki, O. Bahri, 2008, Journal of medical virology.

The spectrum of biochemical alterations associated with organ dysfunction and inflammatory status and their association with disease outcomes in severe COVID-19: A longitudinal cohort and time-series design study

J. Olivier, A. Kimmoun, L. Frimat, 2020, EClinicalMedicine.

[Immunomodulating effect of HCV during the development of chronic hepatitis C: toward new therapeutic approaches].

A. Aubertin, M. Navas, F. Stoll-Keller, 2003, Bulletin de l'Academie nationale de medecine.

Variability in molecular characteristics of Hepatitis E virus quasispecies could modify viral surface properties and transmission

A. de Rougemont, A. Maul, S. Berger, 2021, Journal of viral hepatitis.

Early evolution of hepatitis C virus (HCV) quasispecies after liver transplant for HCV-related disease.

P. Pinson, T. Baumert, S. Fafi-Kremer, 2007, The Journal of infectious diseases.

Epidemiological surveillance of SARS-CoV-2 by genome quantification in wastewater applied to a city in the northeast of France: Comparison of ultrafiltration- and protein precipitation-based methods

L. Mathieu, I. Bertrand, C. Gantzer, 2021, International Journal of Hygiene and Environmental Health.

Impact of Cytomegalovirus Infection on the Outcome of Patients With Cirrhosis: A Preliminary Study

G. Thiéfin, G. Herbein, S. Fafi-Kremer, 2019, Journal of clinical gastroenterology.

Interpretation of Real-Time PCR Results for Hepatitis C Virus RNA When Viral Load Is Below Quantification Limits

J. Pawlotsky, G. Duverlie, J. Izopet, 2011, Journal of Clinical Microbiology.

Climate Change: Impact on Viral Diseases

F. Stoll-Keller, J. Massué, J. Gut, 2008 .

Genotype 1 Hepatitis C Virus Envelope Features That Determine Antiviral Response Assessed through Optimal Covariance Networks

T. Baumert, M. Zeisel, J. Murray, 2013, PloS one.

The presence of RNA cargo is suspected to modify the surface hydrophobicity of the MS2 phage.

Guillaume Bastin, Guillaume Sautrey, C. Gantzer, 2023, Virology.

Impact of the mutational load on the virological response to a first-line rilpivirine-based regimen

V. Calvez, C. Charpentier, P. André, 2018, The Journal of antimicrobial chemotherapy.

Severe acute respiratory coronavirus virus 2 (SARS-CoV-2) seroprevalence among laboratory staff: Safe handling of coronavirus disease 2019 (COVID-19) samples

C. Hartard, N. Agrinier, E. Schvoerer, 2021, Infection control and hospital epidemiology.

An Unexpected Effect of Maraviroc Could Make It a Future Treatment for Sarcoidosis

B. Hoen, A. Tiotiu, F. Goehringer, 2021 .

BRIP1 coding variants are associated with a high risk of hepatocellular carcinoma occurrence in patients with HCV- or HBV-related liver disease

Nathalie, Evelyne, F. Negro, 2016, Oncotarget.

Multicenter Quality Control of Hepatitis C Virus Protease Inhibitor Resistance Genotyping

C. Charpentier, J. Pawlotsky, J. Izopet, 2013, Journal of Clinical Microbiology.

Molecular features of Hepatitis E Virus circulation in environmental and human samples.

S. Berger, I. Bertrand, C. Gantzer, 2018, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.